Drug details

Cinvanti (aprepitant injectable emulsion)

type of Antiemetic Agents, NK1 Receptor Antagonists

Cinvanti (aprepitant) is a substance P/neurokinin-1 (NK 1) receptor antagonist, indicated in adults, in combination with other antiemetic agents, for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin; and nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).

This drug may have the following side effects:

• headache
• fatigue,
• belching, and

The following drugs are related to Cinvanti, either as a replacement or used together:

• Trizivir (abacavir sulfate, lamivudine, and zidovudine)
• Emend Capsules (aprepitant capsules)
• Elspar (asparaginase)
• Tylox (oxycodone and acetaminophen capsules)
• Ultracet (tramadol hydrochloride and acetaminophen tablets)